Health surveillance requires that users know about the benefits of AUGE GES to face diabetes



Saturday 10 November 2018
Health surveillance requires that users know about the benefits of AUGE GES to face diabetes

The invitation is for all users of the healthcare system to know that coverage and treatments that provide protection and basic professional support co-exist with diabetes treatment.

The Health Principle invites the public to learn about the protection and benefits AUGE GES provides to people diagnosed with diabetes as part of the international day of the disease.

Zonal agent (s) Valparaso, Francisco Segura, first recommends knowing through expert consultation what type of diabetes a person is suffering from: We encourage users to first know, through expert consultation, about the type of diabetes, the benefit that GES provides. There are two types, whose housings have specific properties for each of them.

Type 1 diabetes is characterized by persistent high blood glucose levels, a product of pancreatic cell destruction, resulting in an absolute insulin deficiency and a vital dependence on exogenous insulin. It is identified because it can occur at any age, with classical symptoms such as abnormal increase in polydipsia, increased polyuria, abnormal eating (Polyphagia), or diabetic ketoacidosis characterized by dehydration and various degrees of compromise consciousness. Children often start with severe ketoacidosis.

Type 2 diabetes is characterized by persistent high blood glucose, a product of insulin resistance that is usually accompanied by a relative insulin deficiency. It is identified as very symptomatic, which occurs mainly in adulthood, so its diagnosis is performed in about 50% of cases by laboratory tests required for another cause and not by clinical suspicion. Rare clinical symptomatology determines that it is diagnosed with high frequency with slow and chronic complications. This type of diabetes increases with age, overweight / obesity and physical inactivity, which is usually associated with other pathological conditions with high cardiovascular risk such as hypertension and dyslipidemia.

Both types of diabetes have different approaches and opportunities:
In the case of Diabetes 1, all recipients suspected of type 1 diabetes due to altered examination will have access to a diagnostic confirmation by a specialist within 7 days. In the case of a suspicion of decompensation, you will have access to diagnostic confirmation by blood glucose test within 30 minutes of medical care in the emergency room. On the other hand, initiation of treatment for both cases should be done within 24 hours after diagnosis.

In the case of Diabetes 2, all recipients with suspected type 2 diabetes with elevated blood glucose levels will have access to a diagnostic confirmation within 45 days. On the other hand, treatment must be started within 24 hours of diagnosis. In cases requiring the attention of an expert according to the medical indication, this must be done within 90 days of the referral.

Users can go to the website www.superdesalud.gob.cl or contact a regional agency located at Calle lvarez N 646, office 904, Via del Mar.


Source link